Search

Your search keyword '"G. De Berardis"' showing total 53 results

Search Constraints

Start Over You searched for: Author "G. De Berardis" Remove constraint Author: "G. De Berardis"
53 results on '"G. De Berardis"'

Search Results

1. Use of the Diabetes Risk Score for Opportunistic Screening of Undiagnosed Diabetes and Impaired Glucose Tolerance

2. The burden of hospitalization related to diabetes mellitus: A population-based study

3. Epidemiology and outcome research in CKD 5D

4. Persistent platelet activation in patients with type 2 diabetes treated with low doses of aspirin

5. Self-monitoring of blood glucose in non-insulin-treated diabetic patients: a longitudinal evaluation of its impact on metabolic control

6. Randomized Trial of 2 Versus 5 Years of Adjuvant Tamoxifen for Women Aged 50 Years or Older With Early Breast Cancer: Italian Interdisciplinary Group for Cancer Evaluation Study of Adjuvant Treatment in Breast Cancer 01

7. The Relationship Between Physicians’ Self-Reported Target Fasting Blood Glucose Levels and Metabolic Control in Type 2 Diabetes

8. Alternative site blood glucose testing:a multicenter study

9. 40(th) EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004

10. The impact of blood glucose self-monitoring on metabolic control and quality of life in type 2 diabetic patients: an urgent need for better educational strategies

11. The relationship between physicians' self-reported target fasting blood glucose levels and metabolic control in type 2 diabetes. The QuED Study Group--quality of care and outcomes in type 2 diabetes

13. Efficacy, safety and acceptability of the new pen needle 34G × 3.5 mm: a crossover randomized non-inferiority trial; AGO 02 study.

14. Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes.

15. Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes: A Meta-analysis.

16. [Not Available].

17. The Drug Derived Complexity Index (DDCI) Predicts Mortality, Unplanned Hospitalization and Hospital Readmissions at the Population Level.

18. Association of Drug Effects on Serum Parathyroid Hormone, Phosphorus, and Calcium Levels With Mortality in CKD: A Meta-analysis.

19. The long-term effects of stillbirth on women with and without gestational diabetes: a population-based cohort study.

20. Patient satisfaction with in-centre haemodialysis care: an international survey.

21. Effect of pioglitazone versus metformin on cardiovascular risk markers in type 2 diabetes.

22. The burden of hospitalization related to diabetes mellitus: a population-based study.

23. Association of aspirin use with major bleeding in patients with and without diabetes.

24. Sexual dysfunction in women with ESRD requiring hemodialysis.

25. Prevalence and correlates of erectile dysfunction in men on chronic haemodialysis: a multinational cross-sectional study.

26. Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study.

27. Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials.

28. Management of erectile dysfunction in general practice.

29. Glycated haemoglobin or mean blood glucose as indicators of metabolic control in Type 2 diabetes?

30. Quality of diabetes care predicts the development of cardiovascular events: results of the QuED study.

31. Persistent platelet activation in patients with type 2 diabetes treated with low doses of aspirin.

32. Identifying patients at risk for microalbuminuria via interaction of the components of the metabolic syndrome: a cross-sectional analytic study.

33. Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins.

34. AHA/ADA vs. ESC/EASD recommendations on aspirin as a primary prevention strategy in people with diabetes: how the same data generate divergent conclusions.

36. Clinical and psychological predictors of incidence of self-reported erectile dysfunction in patients with type 2 diabetes.

37. Twelve-year mortality results of a randomized trial of 2 versus 5 years of adjuvant tamoxifen for postmenopausal early-stage breast carcinoma patients (SITAM 01).

38. Are Type 2 diabetic patients offered adequate foot care? The role of physician and patient characteristics.

39. Longitudinal assessment of quality of life in patients with type 2 diabetes and self-reported erectile dysfunction.

40. Self-monitoring of blood glucose in non-insulin-treated diabetic patients: a longitudinal evaluation of its impact on metabolic control.

41. Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study.

42. Impact of physicians' beliefs and practices on cholesterol levels in patients with type 2 diabetes: a longitudinal assessment.

43. Prevention of cardiovascular disease in type-2 diabetes: how to improve the clinical efficacy of aspirin.

44. Correlates of satisfaction for the relationship with their physician in type 2 diabetic patients.

45. Quality of care and outcomes in type 2 diabetic patients: a comparison between general practice and diabetes clinics.

46. Physician attitudes toward foot care education and foot examination and their correlation with patient practice.

47. Randomized trial of 2 versus 5 years of adjuvant tamoxifen for women aged 50 years or older with early breast cancer: Italian Interdisciplinary Group Cancer Evaluation Study of Adjuvant Treatment in Breast Cancer 01.

48. Identifying patients with type 2 diabetes with a higher likelihood of erectile dysfunction: the role of the interaction between clinical and psychological factors.

49. Role of organizational factors in poor blood pressure control in patients with type 2 diabetes: the QuED Study Group--quality of care and outcomes in type 2 diabetes.

50. Alternative site blood glucose testing: a multicenter study.

Catalog

Books, media, physical & digital resources